<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">Aspergillosis</z:e> remains to be a life-threatening complication in immunocompromised patients </plain></SENT>
<SENT sid="1" pm="."><plain>However, <z:e sem="disease" ids="C0851807" disease_type="Disease or Syndrome" abbrv="">Aspergillus infection</z:e> can be observed in non-immunocompromised individuals in rare cases </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of liver <z:e sem="disease" ids="C0276651" disease_type="Disease or Syndrome" abbrv="">aspergilloma</z:e> in a <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patient under relatively intact immune status </plain></SENT>
<SENT sid="3" pm="."><plain>Therapeutic strategy for this rare condition was extensively discussed and caspofungin <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> single agent first-line therapy was applied after careful consideration </plain></SENT>
<SENT sid="4" pm="."><plain>Encouraging clinical and radiologic improvements were achieved in response to the antifungal salvage </plain></SENT>
<SENT sid="5" pm="."><plain>Our long-term follow-up study also revealed a favorable prognosis </plain></SENT>
<SENT sid="6" pm="."><plain>Based on this experience, we suggest caspofungin <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> as first-line therapy for treatment plans of liver <z:e sem="disease" ids="C0276651" disease_type="Disease or Syndrome" abbrv="">aspergilloma</z:e> </plain></SENT>
</text></document>